Back
State Bank of India Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
62
SBKFF
State Bank of India
Last Price:
$85.00
Seasonality Move:
8.89%
Buy
53
SRPT
Sarepta Therapeutics
Last Price:
$71.79
Seasonality Move:
17.94%
Buy
62
State Bank of India (SBKFF)
is a Buy
Is State Bank of India a Buy, Sell or Hold?
-
The current State Bank of India [SBKFF] share price is $85.00. The Score for SBKFF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
SBKFF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $71.81. The Score for SRPT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SBKFF Stock Price Chart
What is State Bank of India's stock price today?
-
The State Bank of India share price today is $85.00The current trend is relatively stagnant and SBKFF is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $71.81Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
SBKFF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.74 | Buy |
Relative Strength Index (14 RSI): | 55.09 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (80.54 - 86.3) | Buy |
Bollinger Bands (100): | (81.9 - 97.62) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -9.92 | Sell |
Relative Strength Index (14 RSI): | 28.2 | Sell |
Chaikin Money Flow: | -798774 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (80.35 - 108.37) | Sell |
Bollinger Bands (100): | (98.9 - 127.68) | Sell |
SBKFF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 85.56 | Sell |
20-day SMA: | 84.09 | Buy |
50-day SMA: | 82.51 | Buy |
200-day SMA: | 94.91 | Sell |
8-day EMA: | 85.2 | Sell |
20-day EMA: | 84.45 | Buy |
50-day EMA: | 85.07 | Sell |
200-day EMA: | 89.19 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 74.46 | Sell |
20-day SMA: | 91.18 | Sell |
50-day SMA: | 104.46 | Sell |
200-day SMA: | 124.15 | Sell |
8-day EMA: | 77.38 | Sell |
20-day EMA: | 87.73 | Sell |
50-day EMA: | 100.49 | Sell |
200-day EMA: | 116.63 | Sell |
State Bank of India Earnings Growth & SBKFF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.
State Bank of India Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |